Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Senile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00004845
What this trial is testing

Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)
Not applicableLooking for participantsNCT03621839
What this trial is testing

New CSF Biomarkers for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaNeurodegenerative Diseases
Central Hospital, Nancy, France 50,000
Post-approval studies (Phase 4)Study completedNCT02267057
What this trial is testing

Efficacy of Pain Treatment on Depression in Patients With Dementia

Who this might be right for
DepressionPainDementia
University of Bergen 163
Not applicableNot Yet RecruitingNCT07613957
What this trial is testing

Comparison of AI-based Smartphone-derived Gait Parameters With the Gold Standard

Who this might be right for
Gait Analysis on Healthy Adults
Technical University of Munich 40
Large-scale testing (Phase 3)Study completedNCT00000173
What this trial is testing

Memory Impairment Study (Mild Cognitive Impairment Study)

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)
Early research (Phase 1)Study completedNCT05787041
What this trial is testing

The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects

Who this might be right for
Alzheimer Disease
South China Center For Innovative Pharmaceuticals 16
Not applicableNot Yet RecruitingNCT07388186
What this trial is testing

Benefits of Strength Training in Informal Caregivers of Patients With Alzheimer's Disease

Who this might be right for
FrailtyCaregiver BurdenAnxiety
University of Salamanca 62
Large-scale testing (Phase 3)Ended earlyNCT00939783
What this trial is testing

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 649
Large-scale testing (Phase 3)UnknownNCT00056329
What this trial is testing

Vitamin E in Aging Persons With Down Syndrome

Who this might be right for
Down SyndromeAlzheimer Disease
New York State Institute for Basic Research 350
Testing effectiveness (Phase 2)Study completedNCT02380573
What this trial is testing

Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentMCIAging+2 more
The University of Texas Health Science Center at San Antonio 117
Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Testing effectiveness (Phase 2)Study completedNCT02423122
What this trial is testing

A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
EIP Pharma Inc 16
Not applicableStudy completedNCT02915939
What this trial is testing

The Residential Care Transition Module

Who this might be right for
Alzheimer DiseaseDementia
University of Minnesota 240
Not applicableLooking for participantsNCT07309107
What this trial is testing

Deep Learning on Amyloid Positons Emission Tomography

Who this might be right for
Alzheimer Disease
Central Hospital, Nancy, France 40
Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH
Early research (Phase 1)Study completedNCT03056729
What this trial is testing

Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseHealthy Volunteer
Biogen 46
Testing effectiveness (Phase 2)Looking for participantsNCT05336695
What this trial is testing

Assess Fibrin in Brains With AD/ADRD

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
Massachusetts General Hospital 30
Not applicableStudy completedNCT00294307
What this trial is testing

Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers

Who this might be right for
DementiaDementia, VascularAlzheimer Disease+3 more
University of Pennsylvania 814
Large-scale testing (Phase 3)Study completedNCT02791230
What this trial is testing

Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
Pfizer 1,733
Not applicableStudy completedNCT05669365
What this trial is testing

The Care Ecosystem Consortium Effectiveness Study

Who this might be right for
DementiaDementia, VascularDementia With Lewy Bodies+2 more
University of California, San Francisco 1,227
Next Page